1. Introduction {#sec1-medsci-08-00022}
===============

Chloride ions are the principal extracellular strong anions in humans \[[@B1-medsci-08-00022],[@B2-medsci-08-00022]\]. Chloride is substantially involved in the maintenance of acid-base balance, plasma osmotic pressure, hydrochloric acid production, osmotic gradient in the gastrointestinal tract, kidney function, and electrolyte activity in the cellular function \[[@B2-medsci-08-00022]\]. The abnormality of serum chloride levels, or dyschloremia, is associated with several adverse consequences. Previous studies demonstrated that hyperchloremia could result in kidney vasoconstriction, leading to decreased renal blood flow and glomerular filtration rate (GFR). In contrast, hypochloremia might enhance inflammatory response through increased cytokine release \[[@B3-medsci-08-00022],[@B4-medsci-08-00022],[@B5-medsci-08-00022],[@B6-medsci-08-00022],[@B7-medsci-08-00022]\].

Although serum chloride is the major anion commonly reported in the basic metabolic panel, its importance is often overlooked by physicians. The incidence of dyschloremia ranges from 25% to 43% \[[@B8-medsci-08-00022],[@B9-medsci-08-00022],[@B10-medsci-08-00022],[@B11-medsci-08-00022]\]. The causes of hyperchloremia include the loss of bicarbonate ions (either by kidney or gastrointestinal loss), hemodilution, and the infusion of chloride-rich fluids \[[@B2-medsci-08-00022]\]. The causes of hypochloremia include chloride loss by either kidney (e.g., diuretic use), or gastrointestinal loss (e.g., vomiting) \[[@B2-medsci-08-00022]\].

The reports related to the impact of serum chloride levels on patient outcomes have been mostly limited to the field of critical care, and the majority of the previous studies focused on the impact of admission serum chloride on the hospital outcomes \[[@B8-medsci-08-00022],[@B9-medsci-08-00022],[@B10-medsci-08-00022],[@B11-medsci-08-00022],[@B12-medsci-08-00022],[@B13-medsci-08-00022],[@B14-medsci-08-00022],[@B15-medsci-08-00022],[@B16-medsci-08-00022]\]. The knowledge of the impact of serum chloride levels at hospital discharge on long-term mortality after hospital discharge remains limited. Therefore, we conducted this study to assess the risk of one-year mortality based on discharge serum chloride levels in adult hospitalized patients.

2. Materials and Methods {#sec2-medsci-08-00022}
========================

2.1. Study Population {#sec2dot1-medsci-08-00022}
---------------------

This is a single-center cohort study conducted at Mayo Clinic Hospital, Minnesota, USA. We screened all hospitalized adult patients who survived until hospital discharge from 2011 to 2013. We included patients who had at least two serum chloride measurements during hospitalization, of which, one of serum chloride was measured within 24 h of hospital admission to represent admission serum chloride level. We included only the first hospital admission for patients with multiple hospital admissions during the study period. Mayo Clinic institutional review board approved this study (IRB number 15-000024) and waived the need for informed consent due to the minimal risk nature of the study.

2.2. Data Collection {#sec2dot2-medsci-08-00022}
--------------------

We assessed discharge serum chloride as the primary predictor of one-year mortality after hospital discharge. Discharge serum chloride was the last serum chloride measured during hospitalization, while admission serum chloride was the first serum chloride measured during the first 24 h of hospitalization. We calculated estimated glomerular filtration (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration equation \[[@B17-medsci-08-00022]\]. We classified principal diagnoses based on International Classification of Disease, Ninth Revision (ICD-9) codes. We computed the Charlson Comorbidity Index to assess the comorbidity burden of individual patients. We determined patients' vital status from our institutional registry and the Social Security Death Index database.

2.3. Statistical Analysis {#sec2dot3-medsci-08-00022}
-------------------------

We described continuous variables using mean ± standard deviation (SD), and categorical variables using frequency with percentages. We categorized discharge serum chloride into six groups; ≤96, 97--99, 100--102, 103--105, 106--108, and ≥109 mmoL/L based on its distribution at 10th, 25th, 50th, 75th, 90th percentile to evaluate the non-linear association with mortality. We constructed the restricted cubic spline with 4 knots at 96, 100, 104, and 108 mmoL/L of serum chloride to depict the non-linear association between serum chloride and one-year mortality. We compared continuous variables using ANOVA and categorical variables using the Chi-square test. We measured patient survival from hospital discharge and followed until death or one year after hospital discharge. For patients who were lost to follow-up or whose vital status was not known, they were censored at the date of their last inpatient/outpatient follow-up visit. We estimated one-year mortality risk using the Kaplan--Meier method and compared one-year mortality risk among discharge serum chloride groups using the log-rank test. We performed Cox proportional hazard analysis to calculate the hazard ratio (HR) of one-year mortality after hospital discharge for various discharge serum chloride groups using discharge serum chloride of 103--105 mmoL/L as the reference group as it was associated with the nadir mortality at one year. We adjusted multivariable analysis for baseline characteristics in [Table 1](#medsci-08-00022-t001){ref-type="table"} that significantly differed among discharge serum chloride groups (*p* \< 0.05). We performed a stratified analysis based on admission serum chloride (≤99, 100--108, and ≥109 mmoL/L). We performed an interaction test to assess if the association of discharge serum chloride with mortality differed by admission serum chloride by adding the interaction term in the multivariable model. A two-tailed *p*-value of less than 0.05 was considered statistically significant. All analyses were performed using JMP statistical software (version 14.0, SAS Institute, Cary, NC, USA, 2012).

3. Results {#sec3-medsci-08-00022}
==========

3.1. Clinical Characteristics {#sec3dot1-medsci-08-00022}
-----------------------------

We studied a total of 56,907 hospitalized patients who were discharged from our hospital. The mean admission serum chloride was 103 ± 5 mmoL/L. The mean discharge serum chloride was 102 ± 4 mmoL/L. Discharge serum chloride of ≤96, 97--99, 100--102, 103--105, 106--108, and ≥109 mmoL/L was found in 9%, 14%, 26%, 28%, 16%, and 7% of patients, respectively. [Table 1](#medsci-08-00022-t001){ref-type="table"} shows the clinical characteristics based on the discharge serum chloride levels.

3.2. Discharge Serum Chloride and One-Year Mortality {#sec3dot2-medsci-08-00022}
----------------------------------------------------

The median follow-up time was 464 (interquartile range 112--914) days. Of 56,907 patients, 6447 (11.3%) died within one year after hospital discharge. The restricted cubic spline ([Figure 1](#medsci-08-00022-f001){ref-type="fig"}) demonstrates a U-shaped association of discharge serum chloride with one-year mortality, with the nadir mortality associate with discharge serum chloride of 103--105 mmoL/L.

Kaplan--Meier plot ([Figure 2](#medsci-08-00022-f002){ref-type="fig"}) indicates an estimated one-year mortality of 24.2% in discharge serum chloride of ≤96 mmoL/L, 17.0% in 97--99 mmoL/L, 12.7% in 100--102 mmoL/L, 11.0% in 103--105 mmoL/L, 11.8% in 106--108 mmoL/L, and 17.9% in ≥109 mmoL/L (*p* \< 0.001; [Table 2](#medsci-08-00022-t002){ref-type="table"}).

When adjusting for age, sex, race, eGFR, principal diagnosis, comorbidities, in-hospital clinical events and treatments, discharge serum sodium and serum bicarbonate, and admission serum chloride, the risk of one-year mortality in hypochloremic patients was higher when compared with discharge serum chloride of 103--105 mmoL/L for discharge serum chloride levels of 97--99 mmoL/L and ≤96 mmoL/L (hazard ratio (HR): 1.45, 95% confidence interval (CI): 1.32--1.59; and HR: 1.94, 95% CI: 1.72--2.19, respectively). Discharge hyperchloremia of ≥109 mmoL/L was also significantly associated with increased risk of one-year mortality (HR: 1.41 (95% CI: 1.26--1.58), compared with discharge serum chloride of 103--105 mmoL/L; [Table 2](#medsci-08-00022-t002){ref-type="table"}).

3.3. Stratified Analysis Based on Admission Serum Chloride {#sec3dot3-medsci-08-00022}
----------------------------------------------------------

In the subgroup analysis of patients with admission serum chloride of ≤99, and 100--108 mmoL/L, both discharge hypochloremia of ≤99 mmoL/L and discharge hyperchloremia of ≥109 mmoL/L were significantly associated with increased risk of one-year mortality when compared with discharge euchloremia of 100--108 mmoL/L ([Table 3](#medsci-08-00022-t003){ref-type="table"}). In contrast, in the subgroup analysis of patients with admission hyperchloremia of ≥109 mmoL/L, discharge hypochloremia of ≤99 mmoL/L and discharge hyperchloremia of ≥109 mmoL/L were not significantly associated with increased risk of one-year mortality, compared with discharge euchloremia (i.e., 100--108 mmoL/L) ([Table 3](#medsci-08-00022-t003){ref-type="table"}). We found an interaction between admission and discharge serum chloride on one-year mortality (interaction *p* = 0.002).

4. Discussion {#sec4-medsci-08-00022}
=============

The serum chloride level has often been overlooked in practice. Most of the studies generally highlighted the role of serum chloride levels either at the admission or the alteration of serum chloride levels during hospitalization. To our best knowledge, this study is the first study focusing on the impact of the discharge serum chloride levels on the one-year mortality. This large cohort demonstrated a U-shaped association between discharge serum chloride levels and one-year mortality, with the optimal discharge serum chloride levels ranging from 100--108 mmoL/L. The deviation of discharge serum chloride levels from this range resulted in a progressive increase in one-year mortality. In patients with admission serum chloride of ≤108 mmoL/L, both hypochloremia and hyperchloremia at discharge were associated with higher one-year mortality, whereas, in patients with admission serum chloride of ≥109 mmoL/L, none of dyschloremia at discharge was significantly associated with higher one-year mortality.

Several studies previously reported the impact of serum chloride levels on mortality. These investigations demonstrated the effect of hyperchloremia on outcomes, mostly in critically ill patients. Both admission and hospital-acquired hyperchloremia were associated with worse patient outcomes, including a higher risk of acute kidney injury, mortality, and longer length of hospital stay \[[@B9-medsci-08-00022],[@B12-medsci-08-00022],[@B13-medsci-08-00022],[@B14-medsci-08-00022],[@B16-medsci-08-00022],[@B18-medsci-08-00022],[@B19-medsci-08-00022],[@B20-medsci-08-00022]\]. The increase in serum chloride levels out of the proportion to serum sodium levels results in the reduction of strong ion difference, leading to hyperchloremic metabolic acidosis \[[@B2-medsci-08-00022]\]. The severity of acidosis might be enhanced when the hyperchloremic metabolic acidosis is accompanied by anion gap metabolic acidosis.

Our study also demonstrated the association of hypochloremia at discharge with one-year mortality. In contrast to hyperchloremia, the impact of hypochloremia on patient outcomes has not been extensively studied. Only a few investigations demonstrated that hypochloremia was associated with increased adverse outcomes in critically ill patients \[[@B8-medsci-08-00022],[@B10-medsci-08-00022]\]. Besides, hypochloremia was associated with higher mortality in patients with specific conditions, including chronic kidney disease, cardiovascular disease, and acute ischemic stroke \[[@B21-medsci-08-00022],[@B22-medsci-08-00022],[@B23-medsci-08-00022],[@B24-medsci-08-00022],[@B25-medsci-08-00022]\]. Since serum chloride levels, particularly in cardiovascular disease, may indicate the severity of these diseases, hypochloremia might represent a higher severity of illness, resulting in a greater risk of mortality \[[@B2-medsci-08-00022]\]. Also, metabolic alkalosis induced by hypochloremia can cause hypercapnic respiratory acidosis in chronic obstructive pulmonary disease patients, resulting in a higher need for ventilatory support \[[@B15-medsci-08-00022]\]. In the present study, approximately 40% of patients with discharge serum chloride levels \<100 mmoL/L consisted of patients with cardiovascular disease, stroke, and chronic obstructive pulmonary disease. The high proportion of these patients might have magnified the impact of hypochloremia in our study.

In the subgroup analysis, among patients with admission serum chloride levels ≤108 mmoL/L, both hypochloremia and hyperchloremia at discharge were associated with the increased risk of one-year mortality. In contrast, among patients with admission serum chloride ≥109 mmoL/L, hypochloremia and hyperchloremia at discharge were not significantly associated with increased risk of one-year mortality. A previous study demonstrated that the alteration of serum chloride during hospitalization was associated with increased mortality \[[@B26-medsci-08-00022]\]. The upward trend of serum chloride change was significantly associated with increased mortality, whereas the downward trend of serum chloride change was not consistently associated with increased mortality.

This study has some limitations. This was a single-center cohort study. Thus, we cannot establish a causal relationship between discharge serum chloride and mortality. Although we extensively adjusted for known potential confounders, the association might remain unadjusted for unmeasured or unknown factors, such as the causes of dyschloremia, the severity of the underlying disease, the causes of death, the use of intravenous fluid, medications, acid-base status, and the change in serum chloride during hospitalization. Besides, our study population included patients in the white race predominantly and this might limit the generalizability of the result.

5. Conclusions {#sec5-medsci-08-00022}
==============

In conclusion, we demonstrated the U-shape association of discharge serum chloride levels with one-year mortality. The optimal range of discharge serum chloride was from 100--108 mmoL/L, as this range was associated with the nadir of one-year mortality. Both hypochloremia and hyperchloremia at discharge were associated with increased one-year mortality. Future trials are needed to assess the impact of protocols to correct dyschloremia before discharge on patients' outcomes.
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medsci-08-00022-t001_Table 1

###### 

Baseline clinical characteristics.

  Variables                                 All           Discharge Serum Chloride Level (mmoL/L)   *p*-Value                                                       
  ----------------------------------------- ------------- ----------------------------------------- ----------- ------------- ------------- ----------- ----------- ---------
  *N*                                       56,907        5065                                      8017        14,576        16,204        9129        3916        
  Age (year)                                63 ± 17       67 ± 16                                   64 ± 17     62 ± 17       62 ± 17       63 ± 18     63 ± 18     \<0.001
  Male                                      30,447 (54)   2675 (53)                                 4646 (58)   8319 (57)     8689 (54)     4398 (48)   1720 (44)   \<0.001
  Caucasian                                 52,947 (93)   4736 (94)                                 7493 (93)   13,495 (93)   15,096 (93)   8509 (93)   3618 (92)   0.04
  eGFR (mL/min/1.73 m^2^)                   79 ± 28       72 ± 31                                   77 ± 30     81 ± 27       81 ± 27       79 ± 28     72 ± 31     \<0.001
  Principal Diagnosis                                                                                                                                               \<0.001
  - Cardiovascular                          14,537 (26)   1713 (34)                                 2417 (30)   4051 (28)     4056 (25)     1803 (20)   497 (13)    
  - Endocrine/Metabolic                     1677 (3)      224 (4)                                   212 (3)     354 (2)       411 (3)       294 (3)     182 (5)     
  - Gastrointestinal                        5886 (10)     384 (8)                                   667 (8)     1276 (9)      1638 (10)     1191 (13)   730 (19)    
  - Hematology/Oncology                     7686 (14)     652 (13)                                  1218 (15)   2062 (14)     2158 (13)     1147 (13)   449 (11)    
  - Infectious Disease                      2097 (4)      155 (3)                                   230 (3)     471 (3)       532 (3)       439 (5)     270 (7)     
  - Respiratory                             2595 (5)      369 (7)                                   469 (6)     632 (4)       662 (4)       307 (3)     156 (4)     
  - Genitourinary                           1854 (3)      119 (2)                                   191 (2)     334 (2)       492 (3)       393 (4)     325 (8)     
  - Injury/poisoning                        8737 (15)     644 (13)                                  1163 (15)   2308 (16)     2517 (16)     1472 (16)   633 (16)    
  - Other                                   11,838 (21)   805 (16)                                  1450 (18)   3088 (21)     3738 (23)     2083 (23)   674 (17)    
  Charlson Score                            1.9 ± 2.4     2.4 ± 2.6                                 2.1 ± 2.5   1.9 ± 2.4     1.8 ± 2.3     1.9 ± 2.4   2.2 ± 2.5   \<0.001
  Comorbidities                                                                                                                                                     
  - Coronary artery disease                 4788 (8)      566 (11)                                  715 (9)     1200 (8)      1274 (8)      724 (8)     309 (8)     \<0.001
  - Congestive heart failure                4648 (8)      792 (16)                                  874 (11)    1158 (8)      1024 (6)      528 (6)     272 (7)     \<0.001
  - Peripheral vascular disease             2042 (4)      268 (5)                                   352 (4)     513 (4)       460 (3)       302 (3)     147 (4)     \<0.001
  - Stroke                                  4649 (8)      516 (10)                                  630 (8)     1121 (8)      1271 (8)      764 (8)     347 (9)     \<0.001
  - Diabetes mellitus                       12,438 (22)   1469 (29)                                 2018 (25)   3319 (23)     3088 (19)     1695 (19)   849 (22)    \<0.001
  - Chronic obstructive pulmonary disease   5453 (10)     832 (16)                                  1016 (13)   1327 (9)      1300 (8)      672 (7)     306 (8)     \<0.001
  - Cirrhosis                               1632 (3)      171 (3)                                   219 (2)     373 (3)       371 (2)       303 (3)     195 (5)     \<0.001
  Acute myocardial infarction               2762 (5)      237 (5)                                   342 (4)     729 (5)       887 (5)       447 (5)     120 (3)     \<0.001
  Acute kidney injury                       8420 (15)     1316 (26)                                 1552 (19)   2106 (14)     1907 (12)     998 (11)    541 (14)    \<0.001
  Renal replacement therapy                 1180 (2)      379 (7)                                   325 (4)     248 (2)       133 (1)       51 (1)      44 (1)      \<0.001
  Mechanical ventilation                    9418 (17)     1250 (25)                                 1933 (24)   2764 (19)     2209 (14)     921 (10)    341 (9)     \<0.001
  Vasopressor use                           5282 (9)      832 (16)                                  1113 (14)   1496 (10)     1147 (7)      485 (5)     209 (5)     \<0.001
  Admission serum chloride (mmoL/L)         103 ± 5       98 ± 7                                    101 ± 5     103 ± 5       104 ± 4       105 ± 4     107 ± 5     \<0.001
  Discharge serum sodium (mmoL/L)           138 ± 3       134 ± 4                                   136 ± 3     138 ± 2       139 ± 2       141 ± 2     142 ± 3     \<0.001
  Discharge serum bicarbonate (mmoL/L)      26 ± 3        29 ± 4                                    28 ± 3      27 ± 3        26 ± 3        25 ± 3      22 ± 3      \<0.001

Continuous data are presented as mean ± standard deviation (SD); categorical data are presented as count (%); Abbreviation: eGFR, estimated glomerular filtration rate.

medsci-08-00022-t002_Table 2

###### 

The association between discharge serum chloride and one-year mortality.

  Discharge Serum Chloride (mmoL/L)   One-Year Mortality   Univariate Analysis   Multivariate Analysis                       
  ----------------------------------- -------------------- --------------------- ----------------------- ------------------- ---------
  ≤96                                 24.2%                2.46 (2.26--2.66)     \<0.001                 1.94 (1.72--2.19)   \<0.001
  97--99                              17.0%                1.61 (1.49--1.75)     \<0.001                 1.45 (1.32--1.59)   \<0.001
  100--102                            12.7%                1.17 (1.08--1.25)     \<0.001                 1.07 (0.99--1.15)   0.09
  103--105                            11.0%                1 (ref)               \-                      1 (ref)             \-
  106--108                            11.8%                1.09 (0.99--1.18)     0.06                    1.01 (0.93--1.10)   0.81
  ≥109                                17.9%                1.75 (1.59--1.92)     \<0.001                 1.41 (1.26--1.58)   \<0.001

\* Adjusted for age, sex, race, eGFR, principal diagnosis, Charlson comorbidity score, coronary artery disease, congestive heart failure, peripheral vascular disease, stroke, diabetes mellitus, chronic obstructive pulmonary disease, cirrhosis, acute myocardial infarction, acute kidney injury, renal replacement therapy, mechanical ventilation, vasopressor use, discharge serum sodium, discharge serum bicarbonate, and admission serum chloride. Abbreviation: CI, confidence interval; HR, hazard ratio

medsci-08-00022-t003_Table 3

###### 

Subgroup analysis based on admission serum chloride.

  Discharge Serum Chloride (mEq/L)           One-Year Mortality (%)   Univariate Analysis   Multivariate Analysis                       
  ------------------------------------------ ------------------------ --------------------- ----------------------- ------------------- ---------
  Admission serum chloride ≤99 mmoL/L                                                                                                   
  ≤99                                        26.4%                    1.50 (1.38--1.64)     \<0.001                 1.25 (1.11--1.41)   \<0.001
  100--108                                   18.6%                    1 (ref)               \-                      1 (ref)             \-
  ≥109                                       37.5%                    2.31 (1.82--2.92)     \<0.001                 2.06 (1.60--2.66)   \<0.001
  Admission serum chloride 100--108 mmoL/L                                                                                              
  ≤99                                        15.1%                    1.43 (1.32--1.55)     \<0.001                 1.37 (1.23--1.52)   \<0.001
  100--108                                   10.9%                    1 (ref)               \-                      1 (ref)             \-
  ≥109                                       16.1%                    1.58 (1.41--1.77)     \<0.001                 1.24 (1.09--1.42)   0.002
  Admission serum chloride ≥109 mmoL/L                                                                                                  
  ≤99                                        8.9%                     0.90 (0.67--1.17)     0.45                    1.32 (0.94--1.84)   0.10
  100--108                                   9.8%                     1 (ref)               \-                      1 (ref)             \-
  ≥109                                       17.6%                    1.94 (1.62--2.32)     \<0.001                 1.10 (0.86--1.40)   0.46

\* Adjusted for age, sex, race, eGFR, principal diagnosis, Charlson comorbidity score, coronary artery disease, congestive heart failure, peripheral vascular disease, stroke, diabetes mellitus, chronic obstructive pulmonary disease, cirrhosis, acute myocardial infarction, acute kidney injury, renal replacement therapy, mechanical ventilation, vasopressor use, discharge serum sodium, discharge serum bicarbonate, and admission serum chloride. Abbreviation: CI, confidence interval; HR, hazard ratio
